本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

天演藥業

1.78
-0.1400-7.29%
盤後1.77-0.0100-0.56%19:58 EDT
成交量:9.26萬
成交額:17.18萬
市值:8,389.37萬
市盈率:-2.77
高:1.93
開:1.89
低:1.76
收:1.92
52周最高:3.16
52周最低:1.33
股本:4,713.13萬
流通股本:1,273.25萬
量比:2.74
換手率:0.73%
股息:- -
股息率:- -
每股收益(TTM):-0.6428
每股收益(LYR):-0.7423
淨資產收益率:-63.26%
總資產收益率:-24.89%
市淨率:2.21
市盈率(LYR):-2.40

資料載入中...

2025/05/28

SEC問詢函

Form CORRESP - Correspondence
2025/05/23

SEC問詢函

Form CORRESP - Correspondence
2025/03/24

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/11/07

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/03/29

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/03/01

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/19

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/07/10

SEC問詢函

Form CORRESP - Correspondence
2023/06/16

SEC問詢函

Form CORRESP - Correspondence
2023/04/28

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/17

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/02/06

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/05/24

SEC問詢函

CORRESP [Cover] - Correspondence
2022/05/13

SEC問詢函

CORRESP [Cover] - Correspondence
2022/04/29

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2022/04/26

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/02/11

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/09

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/01/26

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/01/26

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals